Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 31, 2026
Shell (SHEL) Delivers Strong Q2 2026 Results with Record Cash Flow and Renewed Buybacks

Shell (SHEL) Delivers Strong Q2 2026 Results with Record Cash Flow and Renewed Buybacks

Key Takeaways

  • Adjusted earnings surged to $9.84 billion, more than doubling the $4.26 billion reported in Q2 2025 and beating the company-provided analyst consensus of $8.92 billion.
  • Cash flow from operations (CFFO) reached $21.4 billion, driven by higher realized commodity prices, a $3.4 billion working capital inflow, and strong trading performance.
  • Shareholder returns remained robust with a new $3.0 billion buyback program announced, marking the 19th consecutive quarter of at least $3 billion in repurchases.
  • Operational records were achieved in Brazil upstream production and refinery utilization, which hit 102%, while the Chemicals segment posted its best quarterly result in over five years.
  • Net debt declined sharply to $41.8 billion from $52.6 billion in the prior quarter, and gearing (net debt as a percentage of total capital) improved to 18.7%.
  • Production volumes dipped to 2,455 thousand barrels of oil equivalent per day (boe/d), down from 2,682 thousand boe/d a year earlier, largely reflecting Middle East disruptions impacting Qatari LNG (liquefied natural gas) volumes.

Earnings Context and Why It Matters

Shell's second-quarter results landed amid extraordinary global energy market conditions. The U.S.-Israeli conflict with Iran disrupted shipping through the Strait of Hormuz, taking significant Qatari LNG volumes offline and injecting fresh volatility into oil and gas markets. For investors, this quarter was a critical test of Shell's integrated business model and its ability to deliver through turbulence. The company had also drawn attention in Q1 2026 after temporarily suspending part of its buyback program in connection with the planned acquisition of Canadian producer ARC Resources. With free cash flow, operational execution, and capital discipline all under scrutiny, Q2 became a defining moment for CEO Wael Sawan's "performance, discipline, simplification" strategy. I also checked this using Tickeron’s AI Screener to see how SHEL compares to others in the industry.

Reported Results

Shell delivered adjusted earnings of $9.84 billion for the second quarter of 2026, comfortably ahead of the $8.92 billion consensus and more than double the $4.26 billion recorded in the same period last year. On a GAAP (Generally Accepted Accounting Principles) basis, income attributable to shareholders reached $10.82 billion, or $1.94 per share, compared with $3.60 billion, or $0.61 per share, in Q2 2025. Adjusted earnings per share (EPS) came in at $1.76.

Revenue and other income totaled $96.35 billion, up sharply from $66.44 billion in the prior-year quarter. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed to $20.71 billion from $13.31 billion a year ago, reflecting broad-based strength across all core divisions.

The standout metric was cash generation. CFFO reached $21.43 billion, compared with $11.94 billion in Q2 2025, while free cash flow surged to $17.52 billion. The Integrated Gas segment contributed $2.69 billion in adjusted earnings, Upstream delivered $3.49 billion, Marketing added $1.33 billion, and Chemicals & Products posted $2.88 billion. Renewables & Energy Solutions remained modest at $79 million.

Cost discipline also featured prominently: Shell has now achieved $5.8 billion in structural cost reductions since 2022, including approximately $700 million delivered in the first half of 2026. Capital expenditure for the quarter was $4.24 billion, keeping the company on track for its full-year guidance of $24–$26 billion. From what I see, reviewing these figures alongside data from Tickeron’s AI tools helps put the results in better perspective.

Market Reaction and Investor Sentiment

Shell's shares responded positively to the Q2 results, rising approximately 1.35% in premarket trading on July 30. Investors appeared to focus on the strength of cash generation and the renewed buyback commitment rather than the decline in headline production volumes. The $21.4 billion CFFO print—nearly double the prior-year figure—reinforced confidence in Shell's ability to fund both shareholder returns and strategic growth investments simultaneously.

Sentiment was further supported by the significant deleveraging evident in the quarter. Net debt dropping by over $10 billion sequentially and gearing falling below 19% signaled a balance sheet that can absorb the ARC Resources acquisition while maintaining generous distributions. The temporary suspension of buybacks in Q1 had unsettled some investors, making the reinstatement of a combined $4.2 billion buyback program (the new $3 billion plus $1.2 billion carried over) a particularly welcome development.

Forward Outlook and Key Factors to Monitor

Looking ahead, Shell enters the third quarter with considerable momentum but also with meaningful uncertainties. The completion of the ARC Resources acquisition—expected in Q3 2026 pending final regulatory approval under Canada's Investment Canada Act—stands as the nearest major catalyst. Once closed, ARC is expected to add roughly $1.5 billion in annual free cash flow and lift Shell's production growth outlook to a 4% compound annual growth rate (CAGR) through 2030, compared with approximately 1% previously.

On the operational front, Shell guided Q3 2026 Integrated Gas production to approximately 570–630 thousand boe/d, with LNG liquefaction volumes of 7.1–7.7 million tonnes. These figures exclude contributions from Qatar and ARC, reflecting the ongoing Middle East disruption and deal timing. Upstream production is expected in the 1,680–1,880 thousand boe/d range.

Investors should also monitor the trajectory of LNG markets heading into the northern hemisphere winter. European gas storage levels remain below normal, and the loss of Qatari volumes has tightened global supply. Shell's trading and optimization arm, which historically contributes 2%–4% to group ROACE (return on average capital employed), may continue benefiting from elevated volatility. On the cost side, management has signaled ambition to reach the top end of the $5–$7 billion structural savings target, with further efficiencies expected from portfolio high-grading and AI-driven productivity initiatives. Potential FID (final investment decision) on LNG Canada Phase 2 before year-end represents an additional growth catalyst worth watching. I’m watching this closely as the numbers unfold.

Research Tools That Support My Process

In my analysis, I regularly turn to Tickeron’s AI Screener to filter energy stocks and compare performance metrics across peers. It allows quick customization of criteria like industry, technical indicators, and market cap, helping surface relevant ideas efficiently without replacing core fundamental review.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SHEL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


SHEL in upward trend: price rose above 50-day moving average on July 13, 2026

SHEL moved above its 50-day moving average on July 13, 2026 date and that indicates a change from a downward trend to an upward trend. In of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on SHEL as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for SHEL crossed bullishly above the 50-day moving average on July 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SHEL advanced for three days, in of 356 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 344 cases where SHEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SHEL moved out of overbought territory on August 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where SHEL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SHEL turned negative on August 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SHEL broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 30, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SHEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.376) is normal, around the industry mean (2.215). P/E Ratio (9.963) is within average values for comparable stocks, (18.338). Projected Growth (PEG Ratio) (1.343) is also within normal values, averaging (1.258). Dividend Yield (0.033) settles around the average of (0.038) among similar stocks. P/S Ratio (0.875) is also within normal values, averaging (2.067).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 118.87B. The market cap for tickers in the group ranges from 39.76K to 656.88B. XOM holds the highest valuation in this group at 656.88B. The lowest valued company is PGAS at 39.76K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 3%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 19%. DEC experienced the highest price growth at 9%, while SKYQ experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was -30%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 55
Price Growth Rating: 41
SMR Rating: 62
Profit Risk Rating: 29
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
SHEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry IntegratedOil

Profile
Details
Industry
N/A
Address
Shell Centre
Phone
+44 2079341234
Employees
103000
Web
https://www.shell.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Shell (SHEL) Delivers Strong Q2 2026 Results with Record Cash Flow and Renewed Buybacks